Aditxt announced the appointment of Sylvia Hermina to its Board of Directors on October 23, 2024. Hermina brings over 20 years of experience in advising public companies on corporate governance, mergers and acquisitions, and shareholder relations. She currently serves as Senior Vice President at Kingsdale Advisors, a governance and proxy solicitation firm.The appointment comes at a strategic time as Aditxt expands its focus beyond immune and precision health into women's health. The company has entered into agreements with Appili Therapeutics for infectious diseases and Evofem Biosciences for women's health initiatives, though both transactions remain subject to shareholder approval and funding conditions.CEO Amro Albanna emphasized the importance of having women's perspectives at the highest decision-making level. Hermina's extensive background includes previous leadership roles at Laurel Hill Advisory Group and The Altman Group, where she specialized in developing communication strategies for NYSE and NASDAQ listed companies.

Aditxt announced the appointment of Sylvia Hermina to its Board of Directors on October 23, 2024. Hermina brings over 20 years of experience in advising public companies on corporate governance, mergers and acquisitions, and shareholder relations. She currently serves as Senior Vice President at Kingsdale Advisors, a governance and proxy solicitation firm.The appointment comes at a strategic time as Aditxt expands its focus beyond immune and precision health into women's health. The company has entered into agreements with Appili Therapeutics for infectious diseases and Evofem Biosciences for women's health initiatives, though both transactions remain subject to shareholder approval and funding conditions.CEO Amro Albanna emphasized the importance of having women's perspectives at the highest decision-making level. Hermina's extensive background includes previous leadership roles at Laurel Hill Advisory Group and The Altman Group, where she specialized in developing communication strategies for NYSE and NASDAQ listed companies.